RIM
CYAD

RS Investment Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

RS Investment Management’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$8.18M Sell
327,363
-2,843
-0.9% -$135K 0.08% 247
2016
Q1 		$14.5M Buy
330,206
+25,268
+8% +$1.03M 0.14% 211
2015
Q4 		$16.6M Buy
304,938
+380
+0.1% +$16.8K 0.15% 200
2015
Q3 		$12.7M Buy
304,558
+66,228
+28% +$3.41M 0.11% 219
2015
Q2 		$12.4M Buy
+238,330
New +$12.8M 0.11% 234

Other funds holding CYAD

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

RS Investment Management's CYAD Position: Q2 2016 in Review

RS Investment Management reduced its Celyad Oncology SA American Depositary Shares (CYAD) stake by 0.86% in Q2 2016, selling an estimated $135K and leaving 327,363 shares worth $8.18M. The position accounts for 0.08% of the portfolio, ranked #247.

RS Investment Management first reported a position in CYAD in Q2 2015 and has held it in 5 quarters since. The position peaked at $16.6M in Q4 2015. 6 funds tracked by Wall St. Rank hold CYAD as of Q2 2016.

  • RS Investment Management held 327,363 shares of Celyad Oncology SA American Depositary Shares worth $8.18M as of Q2 2016.
  • RS Investment Management sold 2,843 Celyad Oncology SA American Depositary Shares shares in Q2 2016, an estimated $135K.
  • Celyad Oncology SA American Depositary Shares made up 0.08% of RS Investment Management's portfolio in Q2 2016, its #247 holding.
  • RS Investment Management first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2015 and has held it in 5 quarters since.
  • RS Investment Management's Celyad Oncology SA American Depositary Shares position peaked at $16.6M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.